What is the recommended first‑line platinum‑taxane chemotherapy for a newly diagnosed woman with stage III/IV ovarian carcinoma and the appropriate second‑line regimens for platinum‑resistant and platinum‑sensitive recurrences?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board

Educational purpose only • Exercise caution as content is pending human review

Article Review Status

Submitted

Under Review

Approved

Last updated: February 16, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Related Questions

What is the recommended first-line treatment for metastatic ovarian cancer in the abdominal area?

What is carcinomatosis (cancer metastasis)?

What conditions are treated with carboplatin?

What are the significant outcomes of treatments for stage 4 (four) ovarian cancer?

What is the life expectancy for stage 4 (four) ovarian cancer?

Are selective serotonin reuptake inhibitors contraindicated in patients with cardiac disease (e.g., prolonged QT interval, recent myocardial infarction, unstable angina, severe heart failure, uncontrolled hypertension) and what precautions should be taken?

What is Kalimate (calcium polystyrene sulfonate) used for?

Should an asymptomatic patient with normal free T3 and free T4 and suppressed TSH (subclinical hyperthyroidism) receive any thyroid treatment before undergoing a colonoscopy?

Can nebivolol and donepezil be used together safely in a patient with a permanent pacemaker placed after a third-degree atrioventricular block?

In a premenopausal woman who received a 3.75 mg leuprolide depot on cycle day 21 and presents on day 3 of menses with bilateral simple ovarian cysts measuring approximately 21 cm total, what are the possible causes and how should this be managed?

What does specialist (maternal‑fetal medicine) monitoring involve, and is it indicated for a pregnant woman with two moderate risk factors for preeclampsia (e.g., nulliparity plus family history of severe preeclampsia or BMI ≥ 35 kg/m²), and does pregnancy‑associated hypertension count as a risk factor that triggers this monitoring?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.